Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 12
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature.
Peng J, Dönnes P, Ardoin SP, Schanberg LE, Lewandowski L; APPLE trial investigators and Childhood Rheumatology Research Alliance (CARRA); Robinson G, Jury EC, Ciurtin C. Peng J, et al. Arthritis Rheumatol. 2024 Mar;76(3):455-468. doi: 10.1002/art.42722. Epub 2023 Dec 19. Arthritis Rheumatol. 2024. PMID: 37786302 Clinical Trial.
PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS).
Smith EMD, Aggarwal A, Ainsworth J, Al-Abadi E, Avcin T, Bortey L, Burnham J, Ciurtin C, Hedrich CM, Kamphuis S, Lambert L, Levy DM, Lewandowski L, Maxwell N, Morand E, Ozen S, Pain CE, Ravelli A, Saad Magalhaes C, Pilkington C, Schonenberg-Meinema D, Scott C, Tullus K, Beresford MW; International cSLE T2T Task Force. Smith EMD, et al. Clin Immunol. 2023 May;250:109296. doi: 10.1016/j.clim.2023.109296. Epub 2023 Mar 17. Clin Immunol. 2023. PMID: 36934849 Free PMC article.
Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force.
Smith EMD, Aggarwal A, Ainsworth J, Al-Abadi E, Avcin T, Bortey L, Burnham J, Ciurtin C, Hedrich CM, Kamphuis S, Levy DM, Lewandowski LB, Maxwell N, Morand EF, Ozen S, Pain CE, Ravelli A, Saad Magalhaes C, Pilkington CA, Schonenberg-Meinema D, Scott C, Tullus K, Beresford MW; cSLE T2T International Task Force. Smith EMD, et al. Ann Rheum Dis. 2023 Jun;82(6):788-798. doi: 10.1136/ard-2022-223328. Epub 2023 Jan 10. Ann Rheum Dis. 2023. PMID: 36627168 Free PMC article.
21 results